XML 20 R10.htm IDEA: XBRL DOCUMENT v3.7.0.1
Cash Equivalents and Short-term Investments
3 Months Ended
Apr. 30, 2017
Investments, Debt and Equity Securities [Abstract]  
Cash Equivalents and Short-term Investments
Cash Equivalents and Short-term Investments
The amortized costs, unrealized gains and losses and estimated fair values of the Company’s cash equivalents and short-term investments as of April 30, 2017 and January 31, 2017 were as follows (in thousands):
 
 
As of April 30, 2017
 
(unaudited)
 
Amortized
Cost
 
Unrealized
Gain
 
Unrealized
Loss
 
Estimated
Fair Value 
Cash equivalents:
 
 
 
 
 
 
 
Money market funds
$
217,651

 
$

 
$

 
$
217,651

Investments:
 

 
 

 
 

 
 

Corporate debt securities
2,500

 

 

 
2,500

Total short-term investments
$
2,500

 
$

 
$

 
$
2,500

Total
$
220,151

 
$

 
$

 
$
220,151


 
As of January 31, 2017
 
Amortized
Cost
 
Unrealized
Gain
 
Unrealized
Loss
 
Estimated
Fair Value 
Cash equivalents:
 
 
 
 
 
 
 
Money market funds
$
10,565

 
$

 
$

 
$
10,565

Investments:
 
 
 

 
 

 
 

Asset-backed securities
1,538

 

 

 
1,538

Corporate debt securities
12,842

 
13

 
(3
)
 
12,852

Total short-term investments
$
14,380

 
$
13

 
$
(3
)
 
$
14,390

Total
$
24,945

 
$
13

 
$
(3
)
 
$
24,955


All short-term investments were designated as available-for-sale securities as of April 30, 2017 and January 31, 2017.
The Company had one and five short-term investments in unrealized loss positions as of April 30, 2017 and January 31, 2017, respectively. There were no material gross unrealized gains or losses from available-for-sale securities and no material realized gains or losses from available-for-sale securities that were reclassified out of accumulated other comprehensive income for the three months ended April 30, 2017 or 2016.
For available-for-sale debt securities that have unrealized losses, the Company evaluates whether (i) it has the intention to sell any of these investments and (ii) whether it is not more likely than not that it will be required to sell any of these available-for-sale debt securities before recovery of the entire amortized cost basis. Based on this evaluation, the Company determined that there were no other-than-temporary impairments associated with short-term investments as of April 30, 2017 and January 31, 2017.
The following tables present the contractual maturities of the Company’s short-term investments as of April 30, 2017 and January 31, 2017 (in thousands):
 
 
As of April 30, 2017
 
(unaudited)
 
Amortized
Cost
 
Estimated
Fair Value
Due within one year
$
2,500

 
$
2,500

Due between one to five years

 

 
$
2,500

 
$
2,500

 
As of January 31, 2017
 
Amortized
Cost
 
Estimated
Fair Value
Due within one year
$
12,842

 
$
12,852

Due between one to five years
1,538

 
1,538

 
$
14,380

 
$
14,390